Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NOrth American Study for the Treatment of Recurrent epIstaxis With DoxycycLine: The NOSTRIL Trial

NCT04167085 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT04167085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04167085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NOrth American Study for the Treatment of Recurrent epIstaxis With DoxycycLine: The NOSTRIL Trial
Lead sponsor
University of California, Los Angeles
Phase
Phase 4
Overall status
Completed
Start date
December 18, 2017
Completion date
June 1, 2021
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epistaxis